Market Overview

Not Too Late to Buy Baxter, Jim Cramer Says

Related BAX
Baxter to Divest Vero Cell Vaccines Platform to Nanotherapeutics
Baxter Reports Filing of Form 10 Registration Statement Related to Planned Spinoff of Biopharma Unit
Merck Snags Baxter Executive As CFO (Fox Business)

Coming out of the Twittersphere late Thursday night: Jim Cramer offers advice to an investor who missed out on scooping up shares of Baxter International (NYSE: BAX) before the company announced a breakup into two separate, independent global healthcare companies.

Cramer, who correctly predicted Baxter's breakup, believes the stock can still be bought.

Shares of Baxter opened at $75.68, but closed at $72.80, finishing up 3.8 percent on Thursday.

Posted-In: Jim CramerAnalyst Color Jim Cramer Media Trading Ideas


Related Articles (BAX)

Around the Web, We're Loving...

Get Benzinga's Newsletters